Haptoglobin and its association with the HELLP syndrome [4]

Journal of Medical Genetics

Volumn 40, Issue 3, 2003, Pages 214-216

  Raijmakers, M T M ^a   Roes, E M ^a   Te Morsche, R H M ^a   Steegers, E A P ^b   Peters, W H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN;

ADULT; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HELLP SYNDROME; HUMAN; LETTER; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR;

FEMALE; GENE FREQUENCY; GENOTYPE; HAPTOGLOBINS; HELLP SYNDROME; HUMANS; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY;

EID: 0037338560     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
2. Yano A, Yamamoto Y, Miyaishi S, Ishizu H. Haptoglobin genotyping by allele-specific polymerase chain reaction amplification. Acta Med Okayama 1998;52:173-81.
3. Broughton PF, Roberts JM. Hypertension in pregnancy. J Hum Hypertens 2000;14:705-24.
4. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000;157:2111-22.
5. Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 1998;16:65-73.
6. Chandra T, Padma T, Vishnupriya S, Venkat Raman R. Haptoglobin polymorphism in pregnancy-induced hypertension. Am J Hum Genet Suppl 1991;49:130.
7. Zusterzeel PLM, te Morsche RHM, Raijmakers MTM, Roes EM, Peters WHM, Steegers EAP. Paternal contribution to the risk for pre-eclampsia. J Med Genet 2002;39:44-5.
8. Gratacos E. Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. Eur J Obstet Gynecol Reprod Biol 2000;92:63-6.
9. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222:222-35.
10. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar Am A, Jaffa A Fait G, Lesssing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
11. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6.
12. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323:1213-17.
13. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995;74:772-6.
14. Delanghe JR, Duprez DA, De Buyzere ML, Bergez BM, Callens BY, Leroux-Roels GG, Clement DL. Haptoglobin polymorphism and complications in established essential arterial hypertension. J Hypertens 1993;11:861-7.
15. Chapelle JP, Albert A, Smeets JP, Heusghem C, Kulbertus HE. Effect of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med 1982;307:457-63.
16. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 1998;16:93-104.